The diagnostics company has implemented the SOPHiA DDM™ Platform to enhance its solid tumor...
India-Based Dhiti Omics is Now Live on SOPHiA DDM™
read more
SOPHiA GENETICS Publishes Results of 2024 Annual General Meeting
Shareholders adopt all proposals at Annual General Meeting Boston, US and Rolle, Switzerland, June...
SOPHiA GENETICS Launches New Residual Acute Myeloid (RAM) Application
Novel application supports measurable residual disease (MRD) testing to help monitor cancer and...
IUCT-Oncopole Becomes First French Hospital to Adopt MSK-ACCESS® powered with SOPHiA DDM™
The French comprehensive cancer center implements liquid biopsy test to further its cancer...
SOPHiA GENETICS Announces Kepler Uniklinikum is Live on SOPHiA DDM™ Platform
The Hospital will use SOPHiA DDM™ to enhance its testing and research of blood cancers Boston, MA...
SOPHiA GENETICS Launches Global Consortium, SOPHiA UNITY, to Accelerate Cancer Research, Drug Development, and Data-Driven Patient Care
New collective intelligence network to enable the most advanced research in oncology in support of...
SOPHiA GENETICS to Launch New Whole Genome Sequencing Capabilities
In collaboration with Microsoft and NVIDIA, SOPHiA GENETICS is developing a comprehensive whole...
SOPHiA GENETICS Announces Instituto Mario Penna as New Customer
The Hospital will enhance its testing and research of blood cancers with the SOPHiA DDM™...
AMP Europe
SOPHiA GENETICS is excited to be a part of the Association for Molecular Pathology (AMP) 2024...
Klinikum Klagenfurt am Wörthersee is Live with SOPHiA GENETICS
The SOPHiA DDM™ Platform will help broaden the hospital’s cancer testing and diagnostic...
ESHG Event
We can’t wait to meet you at booth #348, June 1-3. Meet our team to learn...
Customer Spotlight: Katherine Lafferty at Broad Clinical Labs
We recently sat down to talk with Katherine Lafferty, MS, CGC about how Alamut™ Visual Plus helps her overcome the variant interpretation challenges she encounters in her work as a variant analyst. Read our discussion.